摘要
目的观察痰热清注射液治疗慢性阻塞性肺疾病急性加重(AECOPD)患者的临床疗效和安全性。方法选取AECOPD患者108例,随机分为观察组和对照组,在常规吸氧、抗感染、止咳平喘等治疗基础上,观察组给予痰热清注射液,对照组给予沐舒坦注射液治疗,比较两组治疗后的临床疗效。结果观察组临床疗效治愈率优于对照组,观察组体温恢复正常时间明显短于对照组,差异具有统计学意义(P<0.05);总有效率及排痰量比较,差异无统计学意义(P>0.05)。结论痰热清注射液治疗AECOPD疗效确切,安全性好,值得临床推广使用。
objective To observe the therapeutic effect and safety of tanreqing injection on acute exacerbation of chro- nic obstructive pulmonary disease. Method 108 patients with AECOPD were randomly divided into two groups, and all patients were given conventional treatment that included oxygen uptake, anti - infection and relieving cough and asthma. After then the patients in treatment group were treated by tanreqing injection as well as the control group were treated by mucosolvan injection. The clinical effects were observed later. Results Clinical cure rate of treatment group was better than that of control group, the time when the body temperature restores to the normal of treatment group was significantly shorter than that in the control group, the difference between two groups was statistically significant （ P 〈 0.05 ） ; The difference of the total effective rate and sputum quantity between two groups were not statistically significant （ P 〉 0.05 ）. Conclusion The therapeutic effect of Tanreqing Injection in the treatment of AECOPD is certain and worthy of clinical
出处
《现代中医药》
CAS
2012年第6期23-25,共3页
Modern Chinese Medicine
关键词
痰热清
慢性阻塞性肺疾病急性加重
临床疗效
Tanreqing injection
Acute exacerbation of chronic obstructive pulmonary
Clinical efficacy
